Regulation of α-synuclein expression in down syndrome

Journal of Neuroscience Research

Volumn 90, Issue 8, 2012, Pages 1589-1596

  Ramakrishna, Narayan ^a   Meeker, Harry C ^a   Patel, Satyam ^a   Brown, Ted W ^a   El Idrissi, Abdeslem ^b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

synuclein; Downregulation; Neurosin; Ts65Dn mouse

Indexed keywords

ALPHA SYNUCLEIN; KALLIKREIN 6; PHOSPHOPROTEIN PHOSPHATASE 2A; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN REGION; CHROMOSOME 21; CHROMOSOME 6; CONTROLLED STUDY; DOWN SYNDROME; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRISOMY;

ADOLESCENT; ADULT; AGED; ALPHA-SYNUCLEIN; ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; DOWN SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; MICE; MIDDLE AGED; PROTEIN PHOSPHATASE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNAPTIC TRANSMISSION; YOUNG ADULT;

EID: 84861988205     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23049     Document Type: Article

References (38)

1. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A. 2000. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252.
2. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T. 1998. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152: 879-884.
3. Bayer TA, Jakala P, Hartmann T, Egensperger R, Buslei R, Falkai P, Beyreuther K. 1999. Neural expression profile of alpha-synuclein in developing human cortex. Neuroreport 10: 2799-2803.
4. Becker LE, Armstrong DL, Chan F. 1986. Dendritic atrophy in children with Down's syndrome. Ann Neurol 20: 520-526.
5. Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL. 2002. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22: 8797-8807.
6. Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC. 2005. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123: 383-396.
7. Clayton DF, George JM. 1998. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21: 249-254.
8. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, Labaer J, Rochet JC, Bonini NM, Lindquist S. 2006. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313: 324-328.
9. Engidawork E, Lubec G. 2003. Molecular changes in fetal Down syndrome brain. J Neurochem 84: 895-904.
10. Epstein CJ, Berger CN, Carlson EJ, Chan PH, Huang TT. 1990. Models for Down syndrome: chromosome 21-specific genes in mice. Prog Clin Biol Res 360: 215-232.
11. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW. 2004. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55: 174-179.
12. Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, Edwards RH. 2005. Neural activity controls the synaptic accumulation of alpha-synuclein. J Neurosci 25: 10913-10921.
13. Howell MG. 2012. Altered synaptic marker abundance in the hippocampal striatum oriens of Ts65Dn mice is associated wit exuberant expression of versican. ASN NEURO immediate publication AN20110037 (January).
14. Hsu LJ, Mallory M, Xia Y, Veinbergs I, Hashimoto M, Yoshimoto M, Thal LJ, Saitoh T, Masliah E. 1998. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. J Neurochem 71: 338-344.
15. Iwai A, Yoshimoto M, Masliah E, Saitoh T. 1995. Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 34: 10139-10145.
16. Jakes R, Spillantini MG, Goedert M. 1994. Identification of two distinct synucleins from human brain. FEBS Lett 345: 27-32.
17. Kahlem P, Sultan M, Herwig R, Steinfath M, Balzereit D, Eppens B, Saran NG, Pletcher MT, South ST, Stetten G, Lehrach H, Reeves RH, Yaspo ML. 2004. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res 14: 1258-1267.
18. Kleschevnikov AM, Belichenko PV, Villar AJ, Epstein CJ, Malenka RC, Mobley WC. 2004. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci 24: 8153-8160.
19. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. 1998. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
20. Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle M, Nemani V, Chaudhry FA, Edwards RH, Stefanis L, Sulzer D. 2006. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci 26: 11915-11922.
21. Lou H, Montoya SE, Alerte TN, Wang J, Wu J, Peng X, Hong CS, Friedrich EE, Mader SA, Pedersen CJ, Marcus BS, McCormack AL, Di Monte DA, Daubner SC, Perez RG. 2010. Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo. J Biol Chem 285: 17648-17661.
22. Maroteaux L, Scheller RH. 1991. The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Brain Res Mol Brain Res 11: 335-343.
23. Matsumoto L, Takama H, Tamaoka A, Kurisaki H, Date H, Tsuji S, Iwata A. 2010. CpG Demethylation Enhances Alpha-Synucein Expression and Affects the Pathogenesis of Parkinson's Disease. PLOS One 5: 1-9.
24. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. 2000. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20: 3214-3220.
25. Peng X, Tehranian R, Dietrich P, Stefanis L, Perez RG. 2005. Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J Cell Sci 118: 3523-3530.
26. Pennington BF, Moon J, Edgin J, Stedron J, Nadel L. 2003. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev 74: 75-93.
27. Perez RG, Hastings TG. 2004. Could a loss of alpha-synuclein function put dopaminergic neurons at risk? J Neurochem 89: 1318-1324.
28. Pollonini G, Gao V, Rabe A, Palminiello S, Albertini G, Alberini CM. 2008. Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn. Neuroscience 156: 99-106.
29. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
30. Ramakrishna N, Meeker C, Li S, Jenkins EC, Currie JR, Flory M, Lee B, Liu MS, Miller DL. 2005. Polymerase chain reaction method to identify Down syndrome model segmentally trisomic mice. Anal Biochem 340: 213-219.
31. Ramakrishna N, Meeker HC, Li S, Brown WT, Rao R, El Idrissi A. 2009. Upregulation of beta-catenin expression in down syndrome model Ts65Dn mouse brain. Neuroscience 161: 451-458.
32. Sharma M, Burre J, Sudhof TC. 2011. CSPalpha promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity. Nat Cell Biol 13: 30-39.
33. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. 2003. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302: 841.
34. Soitropoulou GP. 2005. Mechanisms of pharmacological modulation of human kallikrein 6 gene expression in breast tumor cell lines. Cell Mol Biol 25 [Gene Methylation in Cancer].
35. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. 1997. Alpha-synuclein in Lewy bodies. Nature 388: 839-840.
36. Tatebe H, Watanabe Y, Kasai T, Mizuno T, Nakagawa M, Tanaka M, Tokuda T. 2010. Extracellular neurosin degrades alpha-synuclein in cultured cells. Neurosci Res 67: 341-346.
37. Voronov SV, Frere SG, Giovedi S, Pollina EA, Borel C, Zhang H, Schmidt C, Akeson EC, Wenk MR, Cimasoni L, Arancio O, Davisson MT, Antonarakis SE, Gardiner K, De Camilli P, Di Paolo G. 2008. Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome. Proc Natl Acad Sci U S A 105: 9415-9420.
38. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG. 2004. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164-173.